doi: 10.1016/j.fas.2013.08.001
Conclusions SIRT1 represents a mechanistically validated target with notable progress in early-stage drug development for MASLD
DKD accounts for 30%50% of all chronic kidney disease (CKD) cases, affecting 285 million patients worldwide (Webster et al., 2017)
1 Introduction 1.1 Literature review methodology This review was conducted by searching PubMed, Scopus, and Google Scholar databases using the keywords Parkinsons disease, -synuclein, dopaminergic neurons, LRRK2, mitochondrial dysfunction, comorbidities, levodopa, and neuroinflammation. Studies published in English between 2000 and 2025 were included
The role of natural polymers in bone tissue engineering
Bulk transfer of fluid in the interstitial compartment of mammary tumors